| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/30/2013 | CN101801930B 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362268 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362235 Carboxamide compounds and methods for using the same |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362040 4-phenylpiperidine derivatives as renin inhibitors |
| 01/29/2013 | US8362038 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | CA2694410C Pyridinoylpiperidines as 5-ht1f agonists |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013012848A1 Benzamides |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012296A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013012135A1 Pre-freeze dried azacitidine preparation, freeze dried azacitidine preparation and method of manufacturing the same |
| 01/24/2013 | WO2013011891A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same |
| 01/24/2013 | WO2013011841A1 Indirubin derivative having highly selective cytotoxicity for malignant tumors |
| 01/24/2013 | WO2013010963A1 Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
| 01/24/2013 | WO2013010862A1 Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |
| 01/24/2013 | WO2013010839A1 Novel and selective ccr2 antagonists |
| 01/24/2013 | WO2013010488A1 An intermediate of statin drugs and preparation thereof |
| 01/24/2013 | US20130023576 Pyrazole Compounds as CRTH2 Antagonists |
| 01/24/2013 | US20130023567 Novel Compounds |
| 01/24/2013 | US20130023551 Dispiro tetraoxane compounds |
| 01/24/2013 | US20130023539 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 01/24/2013 | US20130023538 Heteroaryl Derivatives as CFTR Modulators |
| 01/24/2013 | US20130023534 Pyrazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023532 Indazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023519 5-alkynyl-pyridines |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | CA2841986A1 Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
| 01/24/2013 | CA2841385A1 An intermediate of statin drugs and preparation thereof |
| 01/24/2013 | CA2840284A1 Fungicidal alkyl-substituted 2-[2-chloro-4-(4-chloro-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds |
| 01/24/2013 | CA2834199A1 Benzamides |
| 01/23/2013 | EP2548873A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 01/23/2013 | EP2547687A1 A process using grignard reagents |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | EP2547655A2 Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102892764A Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihyderoxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide |
| 01/23/2013 | CN102892763A Purification of posaconazole and posaconazole intermediates |
| 01/23/2013 | CN102892762A Preparation of posaconazole intermediates |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892758A Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | CN102892754A Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN102892750A Process for the preparation of chiral hydrazides |
| 01/23/2013 | CN102892290A Noxious organism control agent |
| 01/23/2013 | CN102887891A N4-phenyl-quinaz0line-4 -amine derivatives and related compounds |
| 01/23/2013 | CN102295610B Preparation method and application of 1-aryl-2-(1,2,4-triazole-1-group) ethanol |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101935299B Organic electron transport and/or cavitation block material and synthesis method and application thereof |
| 01/23/2013 | CN101805324B Cyclic carbonate compound and synthesis method thereof |
| 01/23/2013 | CN101801382B Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/23/2013 | CN101133033B 5-aminopyrazole derivatives as pesticidal compounds |
| 01/22/2013 | US8357686 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 01/22/2013 | US8357683 Compounds for enzyme inhibition |
| 01/22/2013 | CA2602610C Benzimidazole compound |
| 01/22/2013 | CA2515777C Biphenyl derivatives |
| 01/22/2013 | CA2402402C Use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treating adverse effects of anti-parkinsonian drugs |
| 01/17/2013 | WO2013007792A1 Novel th2 polarizing compounds |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2013007621A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/17/2013 | WO2013007168A1 Preparation and use of pyrrole and dihydropyrrole fused ring compound having insecticidal activity |
| 01/17/2013 | WO2013007106A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | WO2012146724A3 Novel rock inhibitors |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130018073 Indole derivative |
| 01/17/2013 | US20130018065 Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 01/17/2013 | US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/17/2013 | US20130018033 Raf inhibitor compounds and methods of use thereof |
| 01/17/2013 | US20130018030 New compounds, pharmaceutical compositions and uses thereof |
| 01/17/2013 | US20130017196 Substituted imidazole derivatives |
| 01/17/2013 | US20130017171 Methods and compositions for treating hepatitis c virus |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2841095A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/17/2013 | CA2837529A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/16/2013 | EP2546249A1 5-Alkynyl-pyridines |
| 01/16/2013 | EP2546240A1 Benzoylpyrazole compounds and herbicides containing them |
| 01/16/2013 | EP2546236A1 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| 01/16/2013 | EP2545917A1 Novel ep4 agonist |
| 01/16/2013 | EP2545916A1 Use of coumarin derivatives for the preparation of drugs for treating skin diseases |
| 01/16/2013 | EP2545058A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/16/2013 | EP2545047A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 01/16/2013 | EP2545046A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | EP2545045A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 01/16/2013 | EP2545036A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 01/16/2013 | CN102884156A Light-emitting device material and light-emitting device |
| 01/16/2013 | CN102884059A N-酰基环胺衍生物或其可药用盐 N- acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |